tiprankstipranks
Trending News
More News >
Bio-Rad reports Q1 EPS $2.54, consensus $1.78
PremiumThe FlyBio-Rad reports Q1 EPS $2.54, consensus $1.78
11d ago
Is BIO a Buy, Before Earnings?
Premium
Pre-Earnings
Is BIO a Buy, Before Earnings?
13d ago
Bio-Rad price target lowered to $409 from $430 at RBC Capital
Premium
The Fly
Bio-Rad price target lowered to $409 from $430 at RBC Capital
1M ago
Bio-Rad reports Q4 adjusted EPS $2.90, consensus $2.88
PremiumThe FlyBio-Rad reports Q4 adjusted EPS $2.90, consensus $2.88
3M ago
Bio-Rad sees FY25 currency neutral revenue growth 1.5%-3.5%
Premium
The Fly
Bio-Rad sees FY25 currency neutral revenue growth 1.5%-3.5%
3M ago
Bio-Rad to acquire Stilla Technologies
Premium
The Fly
Bio-Rad to acquire Stilla Technologies
3M ago
Bio-Rad price target raised to $450 from $400 at Citi
PremiumThe FlyBio-Rad price target raised to $450 from $400 at Citi
6M ago
Bio-Rad Laboratories Reports Q3 2024 Earnings Growth
Premium
Company Announcements
Bio-Rad Laboratories Reports Q3 2024 Earnings Growth
6M ago
Bio-Rad  reports Q3 EPS $2.01, consensus $1.16
Premium
The Fly
Bio-Rad reports Q3 EPS $2.01, consensus $1.16
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100